Dear colleagues,

On the 4^rd of April, 2025, from 11:00-12:00 CET, we will host our next webinar:

Using co-design to reimagine the regulation of digital drug information infrastructures in the EU
(Mathias Møllebæk, Copenhagen Centre for Regulatory Science)

See below for a detailed description.

To register and receive an invitation for your (Outlook) Calendar (through rivm.nl): Microsoft Virtual Events Powered by Teams

You can also join the Webinar without registration using the following link: Join the meeting

Feel free to share and forward this link to other interested colleagues.

You can find our previous Webinars at the EUPHA Members Resources. 

We look forward to welcoming you to our Webinar. 

Best regards,

EUPHA Foresight Section Team
Henk Hilderink
Ana Vieira
Daniela Moye Holz

Webinar 4 April, 2025: 

Using co-design to reimagine the regulation of digital drug information infrastructures in the EU

By Mathias Møllebæk (Copenhagen Centre for Regulatory Science)

In complex areas like healthcare, efforts to adapt new technologies often become constrained by path dependency, reinforcing existing frameworks and assumptions and limiting opportunities for innovation. To address these challenges, it is essential to move beyond existing constraints and adopt a more open-ended, “blue sky” approach that encourages exploration of alternative ways of framing issues and possibilities. Co-design is both a design and research method that uses collaborative engagement between designers and stakeholders to articulate different viewpoints on a single topic through design activities involving visual tools, such as sketches, prototypes, and diagrams. In this talk we show how we used co-design methodology with different experts to reframe discussions around the regulatory challenges of digitalizing drug safety information in the European Union.

Mathias Møllebæk (he/him) is a researcher at the Copenhagen Centre for Regulatory Science, University of Copenhagen, where he explores the intersection of digital health innovation and regulatory frameworks, European pharmaceutical governance and policy and regulatory theory. Recent work focuses on improving the communication of medicine safety, particularly through digital platforms.

The EUPHA Foresight Section wants to actively bring together professionals, experts, and policy makers to share their knowledge and experiences in Foresight.